Adherence to Antiretroviral Therapy in Patients Participating in a Graduated Cost Recovery Program at an HIV Care Center in South India
- 162 Downloads
In resource-constrained settings, the most frequently cited barrier to optimal antiretroviral therapy (ART) adherence among HIV-infected patients has been the cost of medications. In recent years many subsidized medication programs have been developed to improve ART affordability. A Graduated Cost Recovery program at the largest care center in South India has enrolled 839 eligible patients into four tiers based on an evaluation of their financial information and willingness to pay, of these patients 635 consented to participate in this study. Patients in Tier 1 receive first-line ART at no cost, whereas patients in Tiers 2, 3, and 4 pay 50, 75, and 100%, respectively of the cost of first-line medications based on an assessment of their means. Adherence rates of 95% or greater on 3-day recall were achieved by 84.6% of Tier 1 (n = 156), 71.6% of Tier 2 (n = 141), 72.3% of Tier 3 (n = 242), and 79.2% of Tier 4 (n = 96). These findings suggest patients are highly motivated and that the provision of no-cost ART can promote higher rates of optimal adherence.
KeywordsAntiretroviral therapy India HIV Costs Adherence
Sources of Financial Support: The authors would like to thank the Brown/Tufts Fogarty International Clinical Research and Scholars Program, D43 TW000237-14S1 and the National Institute of Health for their supporting this study.
- 6.Vittinghoff E, Scheer S, O’Malley P, Colfax G, Holmberg SD, Buchbinder SP. Combination antiretroviral therapy and recent declines in AIDS incidence and mortality. JAIDS. 1999;179:717–20.Google Scholar
- 7.Sabate E, editor. Adherence to long-term therapies evidence for action. Geneva, Switzerland: World Health Organization; 2003.Google Scholar
- 16.UNAIDS. UNAIDS/WHO AIDS epidemic update. 2007. Available from http://www.unaids.org/epidemic-update/. Accessed 1 Nov 2009.
- 17.The World Development Indicators database, World Bank. Available from: http://ddp-ext.worldbank.org/CSIDB/getCountryStatInfoXML?id=ind&format=CSIDB (2008). Accessed 1 Nov 2008.
- 24.Sangeetha P, Sripriya P, Ganesh AK, Solomon SS, Duraisamy P. Enhancing HAART through graduated cost recovery in GFATM. In: Poster presentation at XVI international AIDS conference, abstract code: MOPE0706; 2006.Google Scholar
- 27.Gupta I, Trivedi M, Kandamuthan S. Costing of free ART programme of the government of India; 2006. Available from: http://iegindia.org/dis_111_2006.pdf. Accessed 6 Nov 2009.
- 28.Gupta I, Sankar D. Treatment-seeking behaviour and the willingness to pay for antiretroviral therapy of HIV positive patients in India. In: Over M, Heywood P, Gold J, Gupta I, Hira S, Marseille E, editors. HIV/AIDS treatment and prevention in India: modeling the costs and consequences. Washington, DC: World Bank; 2004.Google Scholar
- 39.Schönnesson LN, Williams ML, Ross MW, Diamond PM, Keel P. Three types of adherence to HIV antiretroviral therapy and their association with AIDS diagnosis, medication side-effects, beliefs about antiretroviral therapy, and beliefs about HIV disease. Int J STD AIDS. 2007;18:369–73.CrossRefPubMedGoogle Scholar